Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
46.89
-1.06 (-2.21%)
Aug 4, 2026, 3:04 PM CST

SHE:300832 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
1,6251,6201,8281,6541,328973.7
Depreciation & Amortization
196.4196.4185.61154.33116.4897
Other Amortization
38.2138.2133.4524.8715.6813.4
Loss (Gain) From Sale of Assets
---0.02-0.05-0.62-0.1
Asset Writedown & Restructuring Costs
1.641.640.411.521.521.86
Loss (Gain) From Sale of Investments
-77.14-77.14-118.47-92.94-76.95-71.67
Provision & Write-off of Bad Debts
20.0420.0428.0110.7814.32-7.37
Other Operating Activities
380.9144.9789.84-9.03-50.4126.55
Change in Accounts Receivable
-226.16-226.16-612.94-277.18-240.16-154.66
Change in Inventory
110.78110.78-382.5-136.49-229.95-227.73
Change in Accounts Payable
-211.37-211.37304.2184.02162.1210.03
Change in Other Net Operating Assets
-----80.7193.88
Operating Cash Flow
1,8631,5221,3561,418962.39773.22
Operating Cash Flow Growth
67.33%12.23%-4.36%47.37%24.47%-20.83%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-342.84-311.44-439.2-322.2-403.22-342.94
Sale of Property, Plant & Equipment
0.050.040.110.090.660.24
Sale (Purchase) of Intangibles
-----16.62-
Investment in Securities
442.97-132.79-361.86-53.47-261.5-634.54
Other Investing Activities
44.7730.7995.884.8586.9652.67
Investing Cash Flow
144.95-413.4-705.15-290.73-593.72-924.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Repaid
--4.61-4.24-4.11-4.05-3.59
Net Debt Issued (Repaid)
-4.61-4.61-4.24-4.11-4.05-3.59
Issuance of Common Stock
-----129.56
Repurchase of Common Stock
----16.29-21.62-
Common Dividends Paid
-1,022-1,022-785.96-548.21-471.78-413.4
Other Financing Activities
-99.62----0
Financing Cash Flow
-1,126-1,026-790.2-568.61-497.45-287.43

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-49.36-6.0712.678.69-9.13-14
Net Cash Flow
832.3576.5-126.25567.66-137.9-452.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
1,5201,211917.241,096559.17430.28
Free Cash Flow Growth
101.73%32.02%-16.32%96.02%29.96%-40.39%
Free Cash Flow Margin
33.18%26.46%20.22%27.89%18.35%16.90%
Free Cash Flow Per Share
1.931.541.171.400.710.55
Levered Free Cash Flow
-28.85789.99626.87705.91198.4213.19
Unlevered Free Cash Flow
-28.54790.32627.14706.18198.57213.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
482.66431.05296.84192.8280.06200.54
Change in Working Capital
-321.97-321.97-690.86-324.83-385.54-260.16